A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome
Abstract Background To describe the clinical and microbiological data of carbapenem-resistant Enterobacteriaceae (CRE) infections, the treatment used, hospital- and infection-related mortality, and risk factors for death. Methods A prospective cohort conducted from March 2011 to December 2012. Clini...
Main Authors: | Claudia M. D. de Maio Carrilho, Larissa Marques de Oliveira, Juliana Gaudereto, Jamile S. Perozin, Mariana Ragassi Urbano, Carlos H. Camargo, Cintia M. C. Grion, Anna Sara S. Levin, Silvia F. Costa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-11-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-016-1979-z |
Similar Items
-
Frequency of colistin and fosfomycin resistance in carbapenem-resistant Enterobacteriaceae from a tertiary care hospital in Karachi
by: Qamar S, et al.
Published: (2017-07-01) -
Effectiveness of ceftazidime–avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia
by: Hakeam A. Hakeam, et al.
Published: (2021-08-01) -
Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections
by: Anushree Ulhas Amladi, et al.
Published: (2019-01-01) -
Frequency of Carbapenem, Colistin and Tigecycline Resistant Enterobacteriacae in Medical ICU of a Tertiary Care Hospital in Karachi
by: Shobha Luxmi, et al.
Published: (2018-01-01) -
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
by: Matthew E. Falagas, et al.
Published: (2014-07-01)